Peptonic Medical Stock Current Liabilities
| 28L Stock | 0.0002 0.00 0.00% |
PEPTONIC MEDICAL fundamentals help investors to digest information that contributes to PEPTONIC MEDICAL's financial success or failures. It also enables traders to predict the movement of PEPTONIC Stock. The fundamental analysis module provides a way to measure PEPTONIC MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PEPTONIC MEDICAL stock.
PEPTONIC |
PEPTONIC MEDICAL Company Current Liabilities Analysis
PEPTONIC MEDICAL's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, PEPTONIC MEDICAL has a Current Liabilities of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Drug Manufacturers-Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
PEPTONIC Fundamentals
| Return On Equity | -1.14 | |||
| Return On Asset | -0.52 | |||
| Profit Margin | (1.88) % | |||
| Shares Outstanding | 396.79 M | |||
| Gross Profit | 19.07 M | |||
| Book Value Per Share | 0.72 X | |||
| Earnings Per Share | (0.19) X | |||
| Beta | 0.58 | |||
| Market Capitalization | 3.77 M |
About PEPTONIC MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PEPTONIC MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PEPTONIC MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PEPTONIC MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in PEPTONIC Stock
PEPTONIC MEDICAL financial ratios help investors to determine whether PEPTONIC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PEPTONIC with respect to the benefits of owning PEPTONIC MEDICAL security.